Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hycos Membraderm gel for acute or chronic wounds
RBR-478xd66Recruiting
- Sponsor
- Nipo Serviços Médicos
- Start
- Apr 2025
- Countries
- 1
01
Overview
Randomised, single-blind trial in acute wound, Chronic wound, decubitus ulcer and 1 more (2 arms), sponsored by Nipo Serviços Médicos. Primary endpoints: Efficacy of Hycos Membraderm gel in wound healing and Safety of Hycos Membraderm gel. Started Apr 2025; status: recruiting.
02
Conditions
acute woundChronic wounddecubitus ulcerCutaneous ulcer
Beyond the preview
Go deeper on RBR-478xd66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-478xd66.